Hospital
Shore Memorial Hospital
Shore Memorial Hospital was paid $52.42M by Medicaid between Jan 2018 and Dec 2024, across 271 billing codes. Its largest line is 99284, emergency room visit (serious) — 44% of everything it billed.
33Billing provider infoSHORE MEMORIAL HOSPITAL
SOMERS POINT, NJ 08244
SOMERS POINT, NJ 08244
33aNPI1629070149assigned 08/15/2005
33bProvider typeGeneral Acute Care Hospital
28Total paid$52.42M
24GClaims968,495
24DCodes billed271
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in New Jersey
Rank by total paid#32 of 93
Median peer was paid$30.60M
This provider vs. median1.7×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 114,939 | $7.37M | |
| 2019 | 106,441 | $7.03M | |
| 2020 | 64,540 | $4.15M | |
| 2021 | 116,122 | $6.76M | |
| 2022 | 198,361 | $9.72M | |
| 2023 | 216,151 | $9.98M | |
| 2024incomplete | 151,941 | $7.39M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 44% | 65,050 | 58,667 | $23.22M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 8.9% | 15,598 | 14,122 | $4.64M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 5.7% | 11,940 | 11,401 | $3.01M |
| G0378 | Hospital observation service, per hour | 4.9% | 6,633 | 5,106 | $2.56M |
| 59025 | Fetal non-stress test | 4.5% | 4,263 | 1,494 | $2.34M |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 2.0% | 6,321 | 6,047 | $1.07M |
| C1713 | Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) | 2.0% | 1,357 | 838 | $1.04M |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 1.8% | 4,231 | 4,018 | $968K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 1.5% | 4,641 | 4,292 | $769K |
| 70450 | Computed tomography, head or brain; without contrast material | 1.1% | 7,168 | 6,520 | $593K |
| 76811 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed | 1.1% | 1,830 | 1,793 | $572K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 1.0% | 17,624 | 13,554 | $529K |
259 more codes
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 18,133 | $496K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 13,040 | $443K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 16,513 | $424K |
| OP370 | <1% | 4,523 | $409K | |
| 76801 | <1% | 2,989 | $403K | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 7,680 | $359K |
| OP710 | <1% | 6,697 | $301K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 7,724 | $296K |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | <1% | 2,987 | $290K |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 1,977 | $273K |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 1,423 | $254K |
| 95806 | <1% | 289 | $246K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 46,568 | $226K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 880 | $220K |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 1,863 | $205K |
| 93975 | <1% | 2,693 | $199K | |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | <1% | 1,998 | $183K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 8,057 | $178K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 1,999 | $177K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 1,879 | $174K |
| OP259 | <1% | 79,979 | $174K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 11,063 | $169K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 3,507 | $160K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 35,084 | $154K |
| 71045 | Radiologic examination, chest; single view | <1% | 12,599 | $152K |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | <1% | 771 | $150K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 4,350 | $131K |
| 76830 | Ultrasound, transvaginal | <1% | 1,509 | $127K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 10,791 | $127K |
| 76813 | <1% | 849 | $126K | |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 4,439 | $126K |
| 93017 | <1% | 255 | $115K | |
| 80053 | Comprehensive metabolic panel | <1% | 12,240 | $111K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 5,373 | $108K |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 1,316 | $102K |
| G0283 | Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care | <1% | 2,794 | $102K |
| OP250 | <1% | 54,435 | $99K | |
| 93971 | <1% | 894 | $97K | |
| OP272 | <1% | 14,082 | $94K | |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 68 | $88K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 894 | $75K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 3,541 | $71K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 717 | $68K |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 1,502 | $67K |
| 96376 | <1% | 4,283 | $65K | |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | <1% | 478 | $61K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 7,938 | $58K |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | <1% | 971 | $58K |
| 84484 | <1% | 10,669 | $57K | |
| 73562 | <1% | 2,264 | $55K | |
| 93970 | <1% | 387 | $54K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 1,932 | $53K |
| 73630 | <1% | 2,112 | $52K | |
| 97162 | <1% | 1,314 | $50K | |
| 73610 | <1% | 2,067 | $48K | |
| 99213 | Doctor's office visit, returning patient (routine) | <1% | 2,301 | $47K |
| 74018 | <1% | 2,617 | $47K | |
| 96367 | <1% | 1,300 | $46K | |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | <1% | 137 | $43K |
| 72100 | <1% | 2,004 | $42K | |
| 95810 | Polysomnography; sleep staging with 4 or more additional parameters | <1% | 31 | $40K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 3,058 | $40K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 855 | $40K |
| 70551 | Magnetic resonance imaging, brain; without contrast material | <1% | 282 | $38K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 310 | $38K |
| 74022 | <1% | 1,277 | $35K | |
| 73130 | <1% | 1,480 | $33K | |
| 97161 | <1% | 1,023 | $32K | |
| 73030 | <1% | 1,607 | $32K | |
| 81025 | <1% | 18,444 | $32K | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 1,400 | $31K |
| 36415 | Collection of venous blood by venipuncture | <1% | 11,100 | $30K |
| 80076 | <1% | 9,815 | $28K | |
| 85610 | <1% | 11,671 | $27K | |
| OP271 | <1% | 6,369 | $27K | |
| OP258 | <1% | 13,220 | $26K | |
| 85027 | <1% | 5,840 | $26K | |
| 70496 | <1% | 203 | $24K | |
| 73110 | <1% | 1,002 | $23K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 1,928 | $22K |
| 87088 | <1% | 7,786 | $22K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 5,358 | $22K |
| 85730 | <1% | 9,526 | $22K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 1,912 | $21K |
| 83690 | <1% | 10,074 | $21K | |
| 95800 | <1% | 68 | $21K | |
| 86850 | <1% | 3,795 | $21K | |
| 81003 | <1% | 17,034 | $20K | |
| 87070 | <1% | 5,089 | $19K | |
| 87040 | <1% | 3,482 | $19K | |
| J3490 | Unclassified drugs | <1% | 3,254 | $19K |
| 52000 | <1% | 36 | $19K | |
| 81001 | <1% | 13,231 | $19K | |
| 83735 | <1% | 7,461 | $18K | |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 3,332 | $18K |
| 82948 | <1% | 8,052 | $18K | |
| 76818 | <1% | 137 | $18K | |
| 70498 | <1% | 164 | $17K | |
| 51741 | <1% | 16 | $17K | |
| J1644 | Injection, heparin sodium, per 1000 units | <1% | 4,078 | $17K |
| 94760 | <1% | 1,550 | $17K | |
| C1776 | Joint device (implantable) | <1% | 37 | $17K |
| 88304 | <1% | 1,006 | $17K | |
| 80061 | Lipid panel | <1% | 2,116 | $17K |
| 72040 | <1% | 909 | $17K | |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 1,927 | $16K |
| J2704 | Injection, propofol, 10 mg | <1% | 4,880 | $16K |
| A9270 | Non-covered item or service | <1% | 2,035 | $16K |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 15,316 | $15K |
| 71250 | <1% | 191 | $15K | |
| J2785 | Injection, regadenoson, 0.1 mg | <1% | 93 | $15K |
| 83880 | <1% | 1,585 | $14K | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 1,782 | $14K |
| 87581 | <1% | 1,042 | $14K | |
| 87186 | <1% | 2,429 | $14K | |
| 87641 | <1% | 370 | $14K | |
| J1815 | Injection, insulin, per 5 units | <1% | 1,386 | $14K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 3,705 | $14K |
| 76819 | Fetal biophysical profile; without non-stress testing | <1% | 107 | $14K |
| 76642 | <1% | 134 | $13K | |
| 70486 | <1% | 129 | $12K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 1,642 | $12K |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 4,855 | $12K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 2,845 | $12K |
| 84702 | <1% | 2,160 | $11K | |
| 86900 | <1% | 3,785 | $11K | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 9,982 | $11K |
| 73080 | <1% | 461 | $10K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 16,221 | $10K |
| 73502 | <1% | 336 | $10K | |
| 87077 | <1% | 2,577 | $10K | |
| 87486 | <1% | 1,040 | $10K | |
| 86901 | <1% | 3,813 | $9K | |
| 36591 | <1% | 486 | $9K | |
| 87147 | <1% | 2,576 | $9K | |
| 84145 | <1% | 1,303 | $8K | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 5,996 | $8K |
| 84439 | <1% | 1,528 | $8K | |
| 87081 | <1% | 723 | $8K | |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 5,175 | $7K |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 4,653 | $6K |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 2,769 | $6K |
| 85379 | <1% | 2,519 | $6K | |
| 87807 | <1% | 1,375 | $6K | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 3,863 | $6K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 377 | $6K |
| 80047 | <1% | 1,470 | $6K | |
| 10060 | <1% | 75 | $6K | |
| A9502 | Technetium tc-99m tetrofosmin, diagnostic, per study dose | <1% | 55 | $5K |
| 82728 | <1% | 657 | $5K | |
| 77066 | Tomosynthesis, mammo | <1% | 41 | $5K |
| 29515 | <1% | 121 | $5K | |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 448 | $5K |
| 86140 | <1% | 2,617 | $5K | |
| 87205 | <1% | 1,489 | $4K | |
| 29125 | <1% | 141 | $4K | |
| 82150 | <1% | 2,270 | $4K | |
| 82607 | <1% | 619 | $4K | |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 4,855 | $4K |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 29 | $4K |
| 85652 | <1% | 1,501 | $4K | |
| 73140 | <1% | 219 | $4K | |
| 90715 | <1% | 587 | $4K | |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | <1% | 1,095 | $3K |
| J1650 | Injection, enoxaparin sodium, 10 mg | <1% | 1,421 | $3K |
| 83605 | <1% | 296 | $3K | |
| 83615 | <1% | 1,738 | $3K | |
| J2060 | Injection, lorazepam, 2 mg | <1% | 2,273 | $3K |
| 83550 | <1% | 985 | $3K | |
| J3475 | Injection, magnesium sulfate, per 500 mg | <1% | 1,064 | $3K |
| 82746 | <1% | 421 | $3K | |
| 83540 | <1% | 1,029 | $3K | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 772 | $3K |
| C9113 | Injection, pantoprazole sodium, per vial | <1% | 1,063 | $2K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 138 | $2K |
| J3370 | Injection, vancomycin hcl, 500 mg | <1% | 911 | $2K |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 45 | $2K |
| 82247 | <1% | 336 | $2K | |
| 12001 | <1% | 104 | $2K | |
| 76870 | <1% | 14 | $2K | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 55 | $2K |
| 94664 | <1% | 537 | $2K | |
| 71101 | <1% | 40 | $2K | |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 2,699 | $2K |
| 73590 | <1% | 65 | $2K | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 73 | $1K |
| 82378 | <1% | 27 | $1K | |
| 70460 | <1% | 37 | $1K | |
| 82248 | <1% | 150 | $1K | |
| 82977 | <1% | 167 | $1K | |
| 85014 | <1% | 1,173 | $1K | |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 33 | $1K |
| 73090 | <1% | 73 | $1K | |
| 97165 | <1% | 28 | $1K | |
| 85018 | <1% | 1,170 | $1K | |
| 72072 | <1% | 36 | $973.64 | |
| 82550 | <1% | 419 | $896.19 | |
| L1831 | Knee orthosis, locking knee joint(s), positional orthosis, prefabricated, includes fitting and adjustment | <1% | 52 | $891.18 |
| M0244 | Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring in the home or residence; this includes a beneficiary's home that has been made provider-based to the hospital during the covid-19 public health emergency | <1% | 12 | $882.20 |
| 82805 | <1% | 94 | $857.65 | |
| OP270 | <1% | 469 | $814.17 | |
| 76770 | <1% | 12 | $794.74 | |
| 81002 | <1% | 460 | $768.08 | |
| 86308 | <1% | 243 | $717.35 | |
| 87075 | <1% | 26 | $717.05 | |
| 76820 | <1% | 23 | $657.02 | |
| 88311 | <1% | 154 | $607.05 | |
| 97022 | <1% | 238 | $590.57 | |
| M0222 | Intravenous injection, bebtelovimab, includes injection and post administration monitoring | <1% | 20 | $554.95 |
| J3480 | Injection, potassium chloride, per 2 meq | <1% | 225 | $531.83 |
| J3411 | Injection, thiamine hcl, 100 mg | <1% | 73 | $514.59 |
| J1642 | Injection, heparin sodium, (heparin lock flush), per 10 units | <1% | 474 | $478.58 |
| 84132 | <1% | 458 | $476.02 | |
| 82570 | <1% | 305 | $474.17 | |
| 0003A | <1% | 15 | $460.24 | |
| 96368 | <1% | 51 | $427.89 | |
| 84100 | <1% | 660 | $423.14 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 283 | $411.17 |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | <1% | 238 | $396.72 |
| 12011 | <1% | 41 | $348.99 | |
| G2024 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]) from an individual in a snf or by a laboratory on behalf of a hha, any specimen source | <1% | 21 | $323.02 |
| 86618 | <1% | 56 | $311.36 | |
| J3360 | Injection, diazepam, up to 5 mg | <1% | 78 | $261.44 |
| 87046 | <1% | 80 | $254.04 | |
| J2543 | Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) | <1% | 186 | $252.70 |
| 12002 | <1% | 14 | $233.61 | |
| 86803 | <1% | 12 | $227.13 | |
| 84550 | <1% | 138 | $225.30 | |
| J2470 | Injection, pantoprazole sodium, 40 mg | <1% | 110 | $194.04 |
| 87899 | <1% | 73 | $186.92 | |
| 87427 | <1% | 71 | $164.77 | |
| 87471 | <1% | 14 | $148.20 | |
| J0171 | Injection, adrenalin, epinephrine, 0.1 mg | <1% | 104 | $147.82 |
| 87181 | <1% | 82 | $145.23 | |
| 36416 | <1% | 62 | $140.89 | |
| S0164 | Injection, pantoprazole sodium, 40 mg | <1% | 616 | $138.34 |
| 87045 | <1% | 74 | $137.51 | |
| J1630 | Injection, haloperidol, up to 5 mg | <1% | 167 | $97.73 |
| 87328 | <1% | 12 | $72.85 | |
| 87329 | <1% | 12 | $70.83 | |
| A4217 | Sterile water/saline, 500 ml | <1% | 258 | $63.53 |
| J8499 | Prescription drug, oral, non chemotherapeutic, nos | <1% | 239 | $55.26 |
| 84156 | <1% | 41 | $43.23 | |
| J2710 | Injection, neostigmine methylsulfate, up to 0.5 mg | <1% | 12 | $41.34 |
| G0008 | Administration of influenza virus vaccine | <1% | 28 | $39.00 |
| 85045 | <1% | 16 | $38.52 | |
| J2370 | Injection, phenylephrine hcl, up to 1 ml | <1% | 170 | $35.88 |
| J0360 | Injection, hydralazine hcl, up to 20 mg | <1% | 124 | $32.30 |
| 87493 | <1% | 13 | $32.02 | |
| 90686 | <1% | 16 | $31.34 | |
| A9575 | Injection, gadoterate meglumine, 0.1 ml | <1% | 14 | $30.22 |
| J2920 | Injection, methylprednisolone sodium succinate, up to 40 mg | <1% | 32 | $29.80 |
| 86592 | <1% | 26 | $23.99 | |
| J2371 | Injection, phenylephrine hydrochloride, 20 micrograms | <1% | 157 | $12.45 |
| Q0247 | Injection, sotrovimab, 500 mg | <1% | 13 | $12.26 |
| Q0222 | Injection, bebtelovimab, 175 mg | <1% | 20 | $2.36 |
| Q0244 | Injection, casirivimab and imdevimab, 1200 mg | <1% | 12 | $2.32 |
| 91300 | <1% | 15 | $2.00 | |
| 76937 | 0% | 17 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialJOHNSON, RONALD (PRESIDENT AND CEO)
| Provider | Location | Paid |
|---|---|---|
| Academy Dermatology PC | Colorado Springs, CO | $282K |
| Shore Memorial Hospital | Somers Point, NJ | $246K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.